Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells

Journal of Clinical Investigation

Volumn 118, Issue 1, 2008, Pages 89-99

  Aikawa, Takuma ^a   Whipple, Chery A ^a   Lopez, Martha E ^b   Gunn, Jason ^a   Young, Alison ^a   Lander, Arthur D ^b   Korc, Murray ^a,c  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; BINDING PROTEIN; GLYPICAN 1; GROWTH ARREST SPECIFIC PROTEIN 6; GROWTH ARREST SPECIFIC PROTEIN 7; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER PREVENTION; CELL ISOLATION; CELL PROLIFERATION; CELL TRANSPLANTATION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG METASTASIS; MELANOMA CELL; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; TUMOR GROWTH; WILD TYPE;

ANIMALS; CARRIER PROTEINS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOKINES; DOWN-REGULATION; FEMALE; GLYPICANS; LUNG NEOPLASMS; MELANOMA; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 38149063860     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI32412     Document Type: Article

References (55)

1. McKenna, S., and Eatock, M. 2003. The medical management of pancreatic cancer: a review. Oncologist. 8:149-160.
2. Jemal, A., et al. 2007. Cancer statistics. CA Cancer J. Clin. 57:43-66.
3. Perrimon, N., and Bernfield, M. 2001. Cellular functions of proteoglycans - an overview. Semin. Cell Dev. Biol. 12:65-67.
4. De Cat, B., and David, G. 2001. Developmental roles of the glypicans. Semin. Cell Dev. Biol. 12:117-125.
5. Filmus, J. 2001. Glypicans in growth control and cancer. Glycobiology. 11:19R-23R.
6. Delehedde, M., Lyon, M., Sergeant, N., Rahmoune, H., and Fernig, D.G. 2001. Proteoglycans: pericellular and cell surface multireceptors that integrate external stimuli in the mammary gland. J. Mammary Gland Biol. Neoplasia. 6:253-273.
7. Esko, J.D., and Selleck, S.B. 2002. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem. 71:435-471.
8. David, G. 1993. Integral membrane heparan sulfate proteoglycans. FASEB J. 7:1023-1030.
9. Veugelers, M., et al. 1999. Glypican-6, a new member of the glypican family of cell surface heparan sulfate proteoglycans. J. Biol. Chem. 274:26968-26977.
10. Rapraeger, A.C. 1995. In the clutches of proteoglycans: how does heparan sulfate regulate FGF binding? Chem. Biol. 2:645-649.
11. Kleeff, J., et al. 1998. The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J. Clin. Invest. 102:1662-1673.
12. Kleeff, J., et al. 1999. Stable transfection of a glypican-1 antisense construct decreases tumorigenicity in PANC-1 pancreatic carcinoma cells. Pancreas. 19:281-288.
13. Chen, R.L., and Lander, A.D. 2001. Mechanisms underlying preferential assembly of heparan sulfate on glypican-1. J. Biol. Chem. 276:7507-7517.
14. Kobrin, M.S., et al. 1994. Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer. Biochem. Biophys. Res. Commun. 202:1705-1709.
15. Ebert, M., et al. 1994. Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res. 54:3959-3962.
16. Partanen, J., and Dumont, D.J. 1999. Functions of Tie1 and Tie2 receptor tyrosine kinases in vascular development. Curr. Top. Microbiol. Immunol. 237:159-172.
17. Hendrix, M.J., Seftor, E.A., Kirschmann, D.A., and Seftor, R.E. 2000. Molecular biology of breast cancer metastasis. Molecular expression of vascular markers by aggressive breast cancer cells. Breast Cancer Res. 2:417-422.
18. Lee, O.H., et al. 2006. Expression of the receptor tyrosine kinase Tie2 in neoplastic glial cells is associated with integrin beta1-dependent adhesion to the extracellular matrix. Mol. Cancer Res. 4:915-926.
19. Davis, S., and Yancopoulos, G.D. 1999. The angiopoietins: Yin and Yang in angiogenesis. Curr. Top. Microbiol. Immunol. 237:173-185.
20. Kim, I., et al. 2000. Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Oncogene. 19:4549-4552.
21. Kwak, H.J., So, J.N., Lee, S.J., Kim, I., and Koh, G.Y. 1999. Angiopoietin-1 is an apoptosis survival factor for endothelial cells. FEBS Lett. 448:249-253.
22. Lobov, I.B., Brooks, P.C., and Lang, R.A. 2002. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc. Natl. Acad. Sci. U. S. A. 99:11205-11210.
23. Tait, C.R., and Jones, P.F. 2004. Angiopoietins in tumours: the angiogenic switch. J. Pathol. 204:1-10.
24. Carmeliet, P., and Jain, R.K. 2000. Angiogenesis in cancer and other diseases. Nature. 407:249-257.
25. Itakura, J., et al. 1997. Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. Clin. Cancer Res. 3:1309-13016.
26. Oh, H., et al. 1999. VEGF Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J. Biol. Chem. 274:15732-15739.
27. Fuster, M.M., et al. 2007. Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis. J. Cell Biol. 177:539-549.
28. Hansel, D.E., Kern, S.E., and Hruban, R.H. 2003. Molecular pathogenesis of pancreatic cancer. Annu. Rev. Genomics Hum. Genet. 4:237-256.
29. Korc, M. 1998. Role of growth factors in pancreatic cancer. Surg. Oncol. Clin. N. Am. 7:25-41.
30. Lander, A.D., Stipp, C.S., and Ivins, J.K. 1996. The glypican family of heparan sulfate proteoglycans: major cell-surface proteoglycans of the developing nervous system. Perspect. Dev. Neurobiol. 3:347-358.
31. McKeehan, W.L., Wang, F., and Kan, M. 1998. The heparan sulfate-fibroblast growth factor family: diversity of structure and function. Prog. Nucleic Acid Res. Mol. Biol. 59:135-176.
32. Ding, K., Lopez-Burks, M., Sanchez-Duran, J.A., Korc, M., and Lander, A.D. 2005. Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells. J. Cell Biol. 171:729-738.
33. Zhang, L., et al. 2003. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Cancer Res. 63:3403-3412.
34. Jakobsson, L., et al. 2006. Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. Dev. Cell. 10:625-634.
35. Korc, M. 2003. Pathways for aberrant angiogenesis in pancreatic cancer. Mol. Cancer. 2:8-16.
36. Gengrinovitch, S., et al. 1999. Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165. J. Biol. Chem. 274:10816-10822.
37. Qiao, D., Meyer, K., Mundhenke, C., Drew, S.A., and Friedl, A. 2003. Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 signaling in brain endothelial cells. Specific role for glypican-1 in glioma angiogenesis. J. Biol. Chem. 278:16045-16053.
38. Solorzano, C.C., et al. 2001. Inhibition of growth and metastasis of human pancreatic cancer growing in nude mice by PTK 787/ZK222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases. Cancer Biother. Radiopharm. 16:359-370.
39. Fukasawa, M., and Korc, M. 2004. Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines. Clin. Cancer Res. 10:3327-3332.
40. Sanderson, R.D., Yang, Y., Suva, L.J., and Kelly, T. 2004. Heparan sulfate proteoglycans and heparanase - partners in osteolytic tumor growth and metastasis. Matrix Biol. 23:341-352.
41. Yang, Y., et al. 2007. Heparanase enhances syndecan-1 shedding: A novel mechanism for stimulation of tumor growth and metastasis. J. Biol. Chem. 282:13326-13333.
42. Su, G., Blaine, S.A., Qiao, D., and Friedl, A. 2007. Shedding of syndecan-1 by stromal fibroblasts stimulates human breast cancer cell proliferation via FGF2 activation. J. Biol. Chem. 282:14906-14915.
43. Vlodavsky, I., et al. 1990. Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis. Cancer Metastasis Rev. 9:203-226.
44. Lander, A.D., Nie, Q., and Wan, F.Y. 2002. Do morphogen gradients arise by diffusion? Dev. Cell. 2:785-796.
45. Imanishi, Y., et al. 2007. Angiopoietin-2 stimulates breast cancer metastasis through the alpha(5)beta(1) integrin-mediated pathway. Cancer Res. 67:4254-4263.
46. Lohr, M., et al. 1996. Expression and function of receptors for extracellular matrix proteins in human ductal adenocarcinomas of the pancreas. Pancreas. 12:248-259.
47. Folkman, J. 2003. Angiogenesis and apoptosis. Semin. Cancer Biol. 13:159-167.
48. Kornmann, M., Arber, N., and Korc, M. 1998. Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum. J. Clin. Invest. 101:344-352.
49. Luo, J., et al. 2001. Pancreatic cancer cell-derived vascular endothelial growth factor is biologically active in vitro and enhances tumorigenicity in vivo. Int. J. Cancer 92:361-369.
50. Rowland-Goldsmith, M.A., et al. 2002. Soluble type II transforming growth factor-beta receptor attenuates expression of metastasis-associated genes and suppresses pancreatic cancer cell metastasis. Mol. Cancer Ther. 1:161-167.
51. Kornmann, M., Ishiwata, T., Maruyama, H., Beger, H.G., and Korc, M. 2000. Coexpression of FAS and FAS-ligand in chronic pancreatitis: correlation with apoptosis. Pancreas. 20:123-128.
52. Litwack, E.D., et al. 1998. Expression of the heparan sulfate proteoglycan glypican-1 in the developing rodent. Dev. Dyn. 211:72-87.
53. Dong, Q.G., et al. 1997. A general strategy for isolation of endothelial cells from murine tissues. Characterization of two endothelial cell lines from the murine lung and subcutaneous sponge implants. Arterioscler. Thromb. Vasc. Biol. 17:1599-1604.
54. Ketterer, K., et al. 2003. Reverse transcription-PCR analysis of laser-captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancer. Clin. Cancer Res. 9:5127-5136.
55. Fukahi, K., Fukasawa, M., Neufeld, G., Itakura, J., and Korc, M. 2004. Aberrant expression of neuropilin-1 and -2 in human pancreatic cancer cells. Clin. Cancer Res. 10:581-590.